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Abstract 
Health research that seeks the participation of patients requires ethical and administrative 
clearances through the NHS research governance process. This is a two-stage process which 
involves a central Research Ethics Committee (REC), and Research and Development (R&D) at 
specific Trusts. Reflection is undertaken from a researcher’s perspective on their experience of 
negotiating NHS research governance, including R&D within six Trusts, to obtain clearance for a 
qualitative study. The REC offered a clear framework for the researcher, but the committee 
meeting focused on scientific merit to the exclusion of more distinctively ethical matters. 
Furthermore, while the committee was receptive to a qualitative proposal, the administrative 
apparatus of the REC is potentially more conducive to clinical/quantitative studies. While the 
REC offered a clear procedural framework, this was absent from Trusts’ R&D processes. There 
is greater scope for NHS research governance to be undergirded by complementary ethical and 
administrative review processes.   
Introduction 
This paper presents the experience of a researcher who obtained clearance for their health-
related project via the NHS Research Ethics Committee (REC), and subsequently Trusts’ 
Research and Development (R&D) processes. The purpose of the paper is to offer a personal 
account that highlights areas where this overall research governance process might be 
improved, thereby enhancing outcomes for both researchers and the NHS.  
So that I could undertake my qualitative PhD study with Staffordshire University (who were 
the sponsor organisation of this research) I applied to the REC for ethical clearance, and 
following this stage I initially approached five NHS Trusts to seek site-specific R&D clearances 
for my study to allow access to patients via these Trusts1. Shortly after this period I approached 
a further Trust, and it is my experience of working with these six Trusts that is under 
consideration in this paper. Undertaking a multi-site study presented an opportunity to 
formulate distinctive insights on the pursuit of endorsement for a study via a number of NHS 
organisations.  
The intention is to focus on systemic elements of the process that might be improved; it 
certainly is not a critique of any particular Trust or department. The NHS professionals that I 
worked with throughout this process were consistently approachable and helpful. However, as 
with any system, there are areas that might be enhanced and this paper endeavours to 
highlight where such enhancements could be made.  
 
                                                          
1 These clearances were sought and obtained in 2011. 
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Context 
The role of NHS RECs is to protect research participants (including service users, relatives and 
staff) from harm and to ensure that research is compliant with recognised ethical standards. 
Nevertheless, it has been highlighted that researchers spend a substantial amount of time 
justifying their research to RECs and R&D departments, which erodes research time on projects 
(Watson & Gelling, 2012, p.2097).  
In a reflective paper on studies that failed to obtain REC approval, Folstein & Quilligan 
(2011) recognise that the research ethics review is an important process. However, they report 
that the intensity of the committee meeting was challenging for inexperienced researchers. In 
addition, it was felt that the REC had a quantitative/clinical orientation and was therefore not 
sufficiently receptive to their qualitative and experientially-oriented proposal. This point is 
reinforced by Shaw et al. (2009) who undertook telephone interviews with researchers who had 
sought NHS ethical clearance. Those employing qualitative approaches felt that governance 
systems favoured clinical or laboratory studies. This forced researchers “to pre-empt things that 
they would prefer to keep more open-ended” (Shaw et al., 2009, p.917) thus undermining the 
foundations of their research principles. The authors therefore highlight that there is a tension 
between the required breadth and flexibility of approaches seeking to explore health-related 
domains, and narrowly defined administrative procedures “that stripped away these very 
qualities” (Shaw et al., 2009, p.918).  
The particular mode of ethical scrutiny that should be applied to qualitative research is 
explored by Larkin, de Casterle & Schotmans (2008). It is argued that the constraints of ethical 
application systems might not be conducive to the evaluation of qualitative research proposals. 
A relational ethics perspective is required which recognises the process of how relationships are 
negotiated within research practice. This can prompt a more theoretical evaluation of research 
protocols, shifting emphasis to asking the ethical question rather than solving the ethical 
problem (Larkin, de Casterle & Schotmans, 2008, p.240). Such insights arguably have particular 
relevance within dementia research, as relationships substantially shape the experience of the 
condition and have the scope to sustain or undermine positive self-perceptions of personood 
(Kitwood, 1997). This is not just a matter for detached research scrutiny: the importance of 
conducting oneself appropriately in research encounters, acknowledging the person with the 
condition’s personhood and how it is shaped by social interactions, is of paramount importance 
for the researcher when reflecting on their own conduct (Cowdell, 2010).  
Articles also consider the R&D process specifically. Drawing on their experience of 
navigating the governance process, Jonker, Cox & Marshall (2011) highlight the challenges of 
seeking clearance via more than one NHS Trust. “The authors’ experience is that gaining the 
approval of several trusts’ R&D committees can be a contradictory, lengthy and tedious 
process” (Jonker, Cox & Marshall, 2011, p.262). This can delay research or even dissuade 
potential researchers from pursuing projects. Reflective accounts from other multi-site research 
studies endorse this point. Elwyn et al. (2005) stated that it took 150 days to gain ethical 
clearance. This is argued to be an underestimate by Walters (2005) who sought clearance from 
multiple Primary Care Trusts: it is argued that 9 to 12 months should be allowed for ethical 
approval when seeking this extent of research clearance. This point is reinforced in a journal 
editorial: “There is very often a lack of simplicity and consistency between Research and 
Development (R&D) departments at different NHS Trusts and, consequently, multi-centre 
research in particular, has become a logistical nightmare (Gill & Burnard, 2009:137).  
 
The Journal of New Writing in Health and Social Care                                                        
Volume 1   Issue 1   November 2014     
 
   25 
 
Reflective methodology 
As highlighted in the introduction, this paper is based upon a researcher’s reflective evaluations 
of the NHS research governance process. Reflection in this instance presents a multi-layered 
approach to analysis, based on reflection in action and reflection on action (Schön, 1983). 
Reflection in action accounts for how insights were actively formulated during engagement with 
the governance process through the application stage, interacting with administrators and 
participating in meetings. Reflection on action is predicated on a degree of temporal 
detachment and situates the ‘reflector’ as an observer of prior activity, as they reimagine and 
re-evaluate key interactions and occurrences. The reflective vantage point from which the 
governance process is evaluated will also be defined by later experiences accumulated within 
the research process itself. 
This temporal extensionality produces a somewhat paradoxical situation, whereby the 
reflective researcher operates as an observer analysing themselves as a research subject. Two 
particular and disparate perspectives on the phenomena under enquiry are therefore unified 
under one multifaceted reflective approach. Although the integration of two or more 
perspectives leads to new forms of perception, each contributing perception is still situated, 
leading to a particular rather than a general perspective (Brueur & Roth, 2003, para 4).   
Recognition of the situatedness of reflective insights does not, however, mean that these 
insights must be excessively circumscribed. A credible notion of interpretation can facilitate an 
expansive reflective orientation that accounts for the intersection between situated subjective 
judgements and more extensive/durable features of the social fabric. The hermeneutic circle 
helps to forge conceptual links between these levels of phenomena: this concept relates to 
grasping the iterative relationship between micro-units of experiential data and the research 
process as a whole (Smith, Flowers & Larkin, 2009, p.28). For example, when reflecting on the 
research governance process it is important to recognise that no stage exists in isolation from 
other stages. While a particular administrative feature of governance might be scrutinised, this 
feature should not be viewed as a discrete phenomenon: it will relate to the ethos and 
principles of the broader governance process and could thus have far-reaching implications by 
impacting upon research practices and the orientation and aspirations of researchers.  
The research ethics committee 
A clear framework 
As my study sought the participation of patients with dementia (in semi-structured interviews) it 
was necessary for me to seek clearance from the REC. My application to the REC was 
unsuccessful at the first attempt. Whilst it is disappointing not to receive endorsement for a 
project, the experience of negotiating this stage of ethical clearance was generally positive. The 
REC provides clear timescales for the provision of responses; for example, applicants will 
receive a response within ten working days following the REC meeting, and an overall decision 
is made within 60 days from the initial application. The opportunity for additional feedback was 
also provided and I had a telephone conversation with the Chair about my presentation to the 
REC. It was therefore possible for me to understand where my application required 
strengthening and what measures I could take to ensure that it had a greater chance of 
obtaining clearance at the second attempt.  
As a researcher seeking NHS ethical clearance for the first time, the experience was positive 
and instructive. The clarity over timescales and helpful feedback mitigated some of the anxiety 
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that can be induced by a potentially daunting process – a process that has the scope to hold up 
a project that the researcher is eager to commence. The feedback ensured that I addressed any 
aspects of my protocol that were insufficiently robust. As a result of taking the required 
measures, my application to the REC was successful at the second attempt2.  
 
A focus on scientific merit to the exclusion of ethical scrutiny? 
A query that the REC process raised was whether questions focused on methodology/scientific 
merit to the exclusion of more specific ethical considerations. I have been presented with some 
particular ethical dilemmas during my research and reflected on whether these are the types of 
situation that could be addressed more directly at the REC. Such situations prompted me to 
consider whether the REC had primed me sufficiently with regard to ethical decision-making, or 
if the process was skewed slightly too much towards methodological scrutiny. For example, on 
one occasion during the fieldwork for my study I arrived for an arranged interview with a 
person with dementia and their carer and it appeared that they were not at home. While a 
relatively straightforward matter, it has potentially serious implications if the researcher opts to 
take no action and fails to raise the matter with their clinical contact.  
In addition, the REC meeting could be utilised to help the researcher consider how research 
interactions will be managed in practice; for example, if a participant exhibits emotional 
discomfort or distress. Documenting principles of appropriate practice in the REC application is 
just one stage of this process; managing actual emotional situations in the presence of others is 
substantially more challenging. It is also important to recognise that methodology and ethics 
are not independent realms: technical and ethical matters will intersect (Carson & Fairbairn, 
2002). Ethical review should take in to account this intersection, evaluating both the scientific 
feasibility and ethical dimensions of a proposed approach to enquiry.  
In this study a joint interview approach was selected, with the person with dementia and 
their carer interviewed together. This introduces the requirement for particular evaluations to 
be undertaken if a person exhibits any distress during the interview. The researcher has to be 
mindful of how the process is impacting on both the person with dementia and the carer, and 
also with regard to how any ethically-based decision will affect the relationship between these 
two people. The decision as to whether to continue or terminate an interview is therefore 
rendered more complex by this interactional complexity. It has been highlighted that a potential 
disadvantage of the joint interview process is that it has the potential to stir up antagonisms 
and conflict (Arksey, 1996). This in itself presents a challenge the interviewer, but there could 
also be a lack of consensus between participants as to whether it is appropriate to continue 
with an interview. Under such circumstances the researcher is negotiating a decision-making 
process that has the scope to impact negatively upon both participants.  
Health research is an interactional process often involving contact with vulnerable people: it 
could therefore be efficacious for the ethical clearance process to prepare the researcher as 
much as possible for engagement with this setting. Whilst it is obviously not possible for a REC 
to cover every eventuality that might be encountered, some scenario-based questions focused 
on particular ethical matters might help to establish that the researcher has the capacity to 
effectively negotiate certain dilemmas. This would also help to orient the researcher towards 
the ethically complex situations that could occur, such as those discussed above. Contemplating 
challenging scenarios can help the researcher to anticipate the process of ethical decision-
making and to mentally situate themselves in complex empirical settings, prior to undertaking 
                                                          
2 From the initial application to clearance, the REC process took approximately four months. 
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their research. This is reminiscent of the approach to relational research ethics discussed in the 
‘Context’ section above which focuses on raising questions rather than problem solving (Larkin, 
de Casterle & Schotmans, 2008).  
Furthermore, a system could be put into place whereby researchers can offer feedback on 
ethical matters that have been encountered during the research process. The REC currently 
requests a 12-month update from researchers: this seeks information on a number of topics 
including the sample obtained, whether there have been any protocol breaches, and whether 
the researcher requires any advice on ethical issues. However, it does not request feedback on 
any ethical dilemmas or issues that the researcher has encountered and addressed. A system to 
receive feedback on such matters could enable the NHS to be better informed with regard to 
the ethical issues that arise during research with patients. This system could also inform the 
REC process by offering examples of ethical matters that researchers should be able to evaluate 
before they commence a project.   
Administrative exactitude versus flexible research 
It is highlighted in the ‘Context’ section above that RECs might be more attuned to the 
assessment of quantitative/clinical research to the detriment of more open-ended qualitative 
approaches. I found the REC receptive to my qualitative proposal and any overt preference for 
quantitative/clinical approaches was not discernible. Nevertheless, further to the perspective of 
Shaw et al. (2009), assessing research with reference to a particular set of administrative 
principles is arguably more suitable to the scrutiny of quantitative research designs. There does 
seem to be a tension between seeking precision from the researcher with regard to their 
research proposal and the requirement for flexibility when undertaking qualitative research. It is 
perfectly reasonable that the REC should seek clarity on the intentions of researchers with 
regard to their protocol. What can perhaps be scrutinised is what degree and format of clarity 
can be established prior to undertaking research, and if an inapplicable standard is likely to 
hamper rather than facilitate effective empirical study.  
For example, in this research I sought a sample of younger people with dementia and 
initially set the upper age parameter at age 60, although I stated in my application that this 
could increase to 65 if recruitment proved too difficult. This was deemed too imprecise by the 
REC, and in my resubmission to the panel I removed reference to potential revisions and merely 
stated the initial age parameters that I was setting. Upon commencing the research, it did 
prove excessively challenging recruiting a sample within this age range. I therefore submitted a 
formal amendment to the REC for the age parameter to be raised to 65, as per their 
requirement to notify the committee of any substantial revision to the protocol (i.e. an 
adjustment to the design of the research). This amendment was subsequently approved.  
While it was possible to adjust my research framework it would perhaps be preferable if 
flexibility could be accommodated more readily at the outset of the governance process. A 
substantial amendment to a protocol requires the completion of additional paperwork for 
clearance from the REC (via Chair’s action), which then had to be forwarded by the researcher 
to Trust R&D departments. This therefore generated more work, both for the researcher and 
NHS staff.  
Scrutiny does therefore need to the applied to reconciling the REC’s requirement for stated 
procedural clarity and the reality of research processes that are not so readily coerced into 
predetermined parameters. The imposition of a particular fixed notion of administrative clarity is 
not particularly conducive to the actual processes of research which should be built on flexibility 
and awareness of contingencies. It has been argued that RECs are excessively bureaucratic 
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(Robinson, Murdoch-Eaton & Carter, 2007) and it could also be the case that this lends itself to 
a mode of binary ‘tick-box’ exactitude. This is therefore pursued at the expense of nuanced 
definitions of research effectiveness, which are particularly applicable to certain qualitative 
approaches (Riessman, 1993, p.64).  
This process also has the potential to perplex an inexperienced researcher, who is obliged to 
package their research neatly for the bureaucratic requirements of the REC, only for this 
packaging to become unravelled when presented with the complexities and irregularities of 
empirical study. The argument is not that research should be predicated on rootless, ‘anything 
goes’ grounds. What is being claimed is that a ‘category mistake’ (Ryle, 1969) is being 
committed in imposing a misplaced definition of rigour upon the empirical process. Genuinely 
rigorous research is not defined by fixed and narrow a priori parameters, but is built upon clear 
and flexible foundations upon which meaningful data can be generated. If RECs are increasingly 
able to relate to this actuality then they can help to facilitate and promote effective, rigorous 
research which is predicated on openness and adaptability. 
Research and development  
As highlighted above, the REC process was underpinned by clearly outlined procedures which 
help the researcher to navigate the process. The R&D process lacked this sense of clarity 
overall. Although this might be expected to some degree when dealing with six organisations 
rather than one central committee, this paper considers how certain aspects of the procedure 
might be rendered more effective and consistent. All Trusts require the REC documentation and 
supporting information to be sent prior to initiating their clearance mechanisms. Nevertheless, 
my ongoing involvement in this process varied across the Trusts. Of the six Trusts, the key 
differences in experience can be categorised as follows: 
 At one Trust, the administrative process had some key differences in comparison with 
the other Trusts 
 At one Trust, I had to seek additional management endorsement before clearance was 
obtained 
 At two Trusts, clearance was obtained following a further committee meeting 
 At two Trusts, R&D clearance was received with no further input required from me  
These differences are also addressed in the following table:  
Table 1. Variations in R&D process across NHS organisations 
 
Organisation 
 
Committee 
Additional 
management 
clearance 
GCP 
training 
NHS 
signature 
on SSI 
Clearance 
available 
within (no. of 
months) 
Trust 1     5 
Trust 2     1 
Trust 3     2 
Trust 4     6 
Trust 5     2 
Trust 6     1 
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This paper will now deal with the key matters over which the R&D procedures diverged. 
(The Trust numbers in the table above are used within the text).  
Administrative differences 
R&D offices are required to implement mechanisms and processes that complement the 
particular Trust, or Trusts, that they support. As NHS organisations differ in their structures and 
services, it is therefore likely that there will be differences in the approaches of different R&D 
functions. It would be unreasonable for a researcher not to expect divergent processes to be 
present to some degree across different R&D offices. However, it can be argued that 
procedures should be as consistent as practicable across the NHS to facilitate the effective 
navigation of R&D protocols. The divergence in timescale was also quite pronounced: two R&D 
offices were ready to clear the application within one month; another two were ready within 
two months; but two Trusts took over four months to grant clearance. Having already 
navigated the REC process, waiting several further months for R&D clearance could 
substantially impede a project, particularly if a researcher is dependent on only one or two 
sites.    
Within one R&D office approached for this research project [Trust 1], a number of 
administrative procedures were quite markedly different from the other five offices. For 
example, it was necessary for the researcher to have obtained Good Clinical Practice (GCP) 
training prior to receiving clearance. I had attended this training so it did not delay my 
application, but under other circumstances it may have impeded a researcher from commencing 
their project. Whilst GCP training may be a reasonable requirement for a researcher seeking to 
work with the NHS, this point has been raised to highlight a divergence in stated requirements 
from different Trusts; only one Trust treated GCP clearance as mandatory. Such divergences 
could be disorienting for a researcher seeking clearance from multiple R&D offices, and a 
variety of stipulations across organisations could also delay the progress of a project. 
In addition, a section of the Site-Specific Information Form (SSI) requires a signature from 
the supervisor supporting the project and it is highlighted that a university signatory might be 
appropriate if there is a partner arrangement between the university and the Trust 3. For five 
Trusts it was deemed appropriate for my University supervisor to sign this section. However, 
one particular R&D office [Trust 1] requested the signature of the NHS manager who was 
supporting the research within the Trust. It could have been more clearly established who was 
required to sign the application, and there is perhaps some ambiguity with regard to what 
constitutes a partner relationship between a university and NHS organisation. As highlighted 
above, it might be reasonable to demonstrate support from within the Trust by way of the 
relevant manager/clinician signature. However, as an external researcher it might prove quite 
difficult to obtain this signature, and it did hold up this particular process. It could be argued 
that internal checks undertaken by a R&D department could establish that support measures for 
the research are in place within the Trust, as stated by the researcher in their SSI application.  
Management clearance 
With all R&D applications it is necessary to list the key Trust contact who will assist with this 
research. With all six of my applications I listed the Consultant Psychiatrist as a designated 
contact: these links had been facilitated by my University supervisor. I also listed in the 
                                                          
3 Section 23 of the form ‘Authorisations required prior to R&D approval’ addressed authorisations by managers within 
NHS organisations. However, guidance for this section also stated ‘Where university employers have arrangements in 
place with partner NHS organisations, authorisation from the university to the NHS organisation can be provided in 
this section.’ 
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applications any details of additional professionals I had spoken with who were likely to assist 
with the research. In five cases this was deemed sufficient, but with one application the R&D 
department sought additional confirmation from the team manager who would be helping with 
the recruitment [Trust 2]. This manager then felt that it would have been prudent if 
authorisation had been obtained from their line manager first. This required me to seek 
additional clearance. Eventually the Director of Operations provided an email to confirm that the 
research could proceed. I had contacts within this Trust so was able to seek out this 
confirmation, but if the same situation had arisen at another Trust then this process could have 
become quite tortuous as I sought the relevant level of management clearance.  
It is certainly appropriate that each R&D office should seek to obtain relevant assurances 
from within the Trust that research can be supported without this negatively impacting upon 
service delivery. Nevertheless, with five R&D applications the endorsement of the listed 
Consultant was deemed sufficient. (If further checks with other professionals were undertaken 
then these took place without my involvement.)  
There could therefore be some clearer guidelines for researchers with regard to the level of 
clearance that is required. Does the Consultant overseeing the research offer sufficient 
endorsement, or is the manager actively assisting with the research also required to offer their 
independent confirmation of their service’s capacity to assist? It may of course be reasonable to 
establish feasibility with more than one professional, but in terms of the R&D process for the 
researcher, guidance could perhaps be clearer with regard to the extent of clearance they need 
to obtain to support their application.  
Additional committee stage 
The key divergence across the R&D processes from a researcher perspective was the convening 
of a committee within two of the Trusts. One of these took place without my attendance 
required, but for the other (in a similar situation to the REC) I was invited to attend and present 
on my research protocol. At the majority of the Trusts to which I applied, no further input was 
required from me with regard to the scientific merit of my protocol and it did not appear that a 
formal committee was convened before clearance was obtained. My understanding of the R&D 
process is that it sets out to establish that the organisation can accommodate the project, that 
the researcher is appropriately supervised, and that the costs of the research will be covered by 
the sponsor organisation. Nonetheless, it appeared from the Trusts that convened a committee 
that checking on scientific merit and research methods remained a feature of the process, 
despite these being addressed comprehensively at the REC.  
At the Trust where I was not required to attend [Trust 3], a member of the committee 
emailed following the meeting as they required further clarity on my research protocol, in 
particular with regard to the methodology. This led to an email exchange which spanned two 
weeks until the required clarifications had been provided. An additional aspect of the R&D 
process is the Research Passport which the researcher has to have signed off by their 
nominated lead Trust. This covers checks, undertaken via the sponsor organisation, such as 
Occupational Health and criminal record. The Trust I had nominated as lead undertook this 
aforementioned committee stage and I had received clearance from two other Trusts whilst 
waiting for this process to conclude. I was therefore unable to commence my research with the 
Trusts that had offered clearance, as the Research Passport can only be signed off by the lead 
Trust at the same time they complete their own R&D process4.  
                                                          
4
 The length of time from my initial REC application to the stage where I was able to commence my research was 
approximately six months.  
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This actually led to a situation whereby two Trusts were contacting me with regard to the 
status of my Research Passport, as they were ready to sign-off my R&D application. As REC 
clearance had been granted and I had received R&D endorsement from other Trusts I was 
ostensibly ready to commence my research. Whilst the Research Passport is an essential part of 
the administrative clearance, it could perhaps be considered whether it needs to be tethered to 
the overall R&D process of a particular Trust. The Research Passport and site-specific clearance 
are to some extent separable parts of the process: whilst both are required to work with a 
particular Trust they relate to a different range of checks, with the former linking to checks on 
the individual researcher and the latter relating to the research project. Conceivably when 
working at more than one site, a lead Trust could establish that they are unable to 
accommodate a particular project for site-specific reasons, which accordingly would appear to 
mean that the Research Passport cannot be signed off by them either. This could lead to some 
complications and delay with another Trust then needing to be nominated to sign off the 
Research Passport. These complications could be engendered despite the clearance of the 
Research Passport being otherwise straightforward, with all checks having been undertaken by 
the sponsor organisation.  
With regard to the second Trust that convened a committee [Trust 4] I was invited to 
attend this meeting. At this meeting I addressed a number of questions, the majority of which 
related to research methodology. The period from R&D application to clearance was the longest 
with this Trust. This indicates the potential for delays when a supplementary committee stage is 
employed. 
It must be recognised that Trusts are obliged to follow the procedures that they feel are 
necessary to ensure that they are able to accommodate research. However, the key query with 
regard to utilising a committee at the R&D stage is whether it duplicates evaluations that are 
undertaken at the REC: a second forum that reviews a project’s scientific merit in detail is 
replicating the scrutiny applied at a prior stage of the process. The convening of a committee at 
the R&D stage has the scope to delay the clearance process as it is dependent on a fixed 
meeting date. In addition, in contrast to the REC, no clear timescales are offered for when a 
particular stage of the process will be completed e.g. when a researcher will receive 
confirmation of the committee’s decision following a meeting. 
The relationship between the REC and R&D processes perhaps needs to be documented 
more clearly so that duplication of effort can be avoided. As acknowledged above, Trusts will 
need to ascertain whether research applications are viable, but the REC has already taken on 
some of this task by checking on the ethical and methodological dimensions of the project at a 
meeting attended by a range of professionals and laypeople. Drawing on the notion of ‘lean’, an 
effective system should ensure that the parts of a process are complementary rather than 
repetitious, and thus add value (Fillingham,2007:232-233). By the R&D stage a research 
application has been rigorously checked with regard to methodological and ethical matters at 
the REC. Such a system enables the R&D stage to focus on more site-specific matters, such as 
whether the organisation has the scope to accommodate the research. The aim of this paper is 
not to prescribe the tasks that R&D functions undertake, but merely to suggest that, under any 
system, if the orientation of separate stages is very similar then this might lead to a less than 
optimal focusing of resources. 
Conclusion 
This paper has presented a researcher’s experience of the NHS research governance process, 
and offered insights into how REC and R&D stages of this process interrelate. It can be argued 
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that an effective system will employ complementary stages, present clarity of process, and also 
demonstrate consistency of practice from those engaged in delivery. The REC/R&D system is 
well equipped to offer complementary evaluation of the ethical and practical values of a 
research application.  
My experience, however, suggests that more faith could be placed in the ethical and 
methodological assessments of the REC, to ensure that NHS professionals are not duplicating 
efforts in assessing projects. Furthermore, researchers would benefit from a process under 
which later stages of the process do not repeat the orientation of earlier stages. Scrutiny could 
also be applied with regard to whether more emphasis could be placed on preparing 
researchers for the ethically complex situations that they might encounter. In addition, it can be 
queried whether the requirement of RECs to pursue a specific mode of procedural clarity 
complements the flexibility of process required for effective research practice. This arguably has 
particular implications for qualitative research which is oriented to the exploration of experience 
and relationships. 
It has also been demonstrated that the REC assists the researcher by offering clear 
timescales for its stages and responses. R&D processes lack this clarity. The argument is not 
that R&D processes should be precisely the same across all Trusts, as differences in approach 
may be necessary to meet a particular organisation’s local configurations and requirements; but 
this paper has indicated some key areas of practice that could be clearer and more consistent 
across Trusts. The experience of this research is commensurable with that of other authors 
discussed in the ‘Context’ section of this paper who encountered delays and inconsistencies 
when seeking clearance for multi-site studies.  
It has to be recognised that Trusts are obliged to ensure that they can accommodate 
research that is ethically sound and must take the measures they feel are necessary to make 
sure that the required evaluations are undertaken. This paper does not set out to challenge this 
principle, but suggests that scrutiny could be applied to aspects of the REC/R&D process to 
ensure that the NHS is able to undertake such evaluations more effectively. 
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